Jason Aryeh
Director · Orchestra BioMed Holdings, Inc.
- 2024
- Jun 25, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Aryeh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M in LGND purchases and sales in the last 12 months
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
- Nancy Ryan Gray - $1.35M in LGND purchases and sales in the last 12 months
- Stephen L. Sabba - $1.16M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Aryeh?
Jason Aryeh is a corporate insider, tracked as Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jason Aryeh last file a Form 4?
The most recent primary Form 4 on record is dated 25 June 2026, one of 10 filings going back to 2024.
Has Jason Aryeh been buying or selling stock?
Recorded transactions: 3 open-market purchases ($40K) and 5 open-market sales ($2.96M) across all tracked filings.
